Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free PPCB Stock Alerts

Propanc Biopharma (PPCB) Stock Chart & Stock Price History

Propanc Biopharma logo
$1.01 -0.01 (-0.98%)
As of 04:00 PM Eastern
Compare

Propanc Biopharma Stock Price Performance

The Propanc Biopharma (PPCB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 97.96%, with a year-to-date return of -92.47%. In the past month, the stock has decreased 0.98%, reflecting recent market activity.

As of the latest close, Propanc Biopharma traded at $1.01 with a market cap of $2.30 million and volume of 177,632 shares. Five years ago, the stock traded at a split-adjusted price of $810.00, representing a 99.88% decrease over that period. At the time, it had a market cap of $252 thousand and a volume of 16 shares.

Receive PPCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-25.19%
1 Month
Performance
-0.98%
3 Month
Performance
-39.16%
Year-To-Date
Performance
-92.47%
1 Year
Performance
-97.96%
5 Year
Performance
-99.88%

PPCB Stock Chart for Friday, September, 4, 2026

PPCB Chart by TradingView

Propanc Biopharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/04/2026$1.02$1.01
-0.98%		$1.05$0.97177,632 shs$2.30 million
09/03/2026$1.03$1.02
-0.97%		$1.04$0.97343,292 shs$2.33 million
09/02/2026$1.13$1.03
-8.85%		$1.16$1.00482,921 shs$2.35 million
09/01/2026$1.35$1.13
-16.30%		$1.28$1.11587,851 shs$2.58 million
08/31/2026$1.35$1.35$1.48$1.25788,500 shs$3.08 million
08/28/2026$2.23$1.35
-39.46%		$1.94$1.314.00 million shs$3.08 million
08/27/2026$1.07$2.23
+108.41%		$4.13$1.9896.62 million shs$5.08 million
08/26/2026$1.13$1.07
-5.31%		$1.12$1.079,167 shs$2.44 million
08/25/2026$1.16$1.13
-2.16%		$1.16$1.0814,985 shs$2.58 million
08/24/2026$1.08$1.16
+6.94%		$1.19$1.0822,999 shs$2.63 million
08/21/2026$1.10$1.08
-1.82%		$1.12$1.0525,135 shs$2.46 million
08/20/2026$1.14$1.10
-3.51%		$1.18$1.1020,485 shs$2.51 million
08/19/2026$1.16$1.14
-1.72%		$1.19$1.1035,652 shs$2.60 million
08/18/2026$1.15$1.16
+0.87%		$1.19$1.1030,000 shs$2.64 million
08/17/2026$1.22$1.15
-5.74%		$1.27$1.1546,463 shs$2.62 million
08/14/2026$1.22$1.22$1.29$1.2039,411 shs$2.78 million
08/13/2026$1.21$1.22
+0.83%		$1.26$1.2033,956 shs$2.78 million
08/12/2026$1.17$1.21
+3.42%		$1.26$1.1739,039 shs$2.76 million
08/11/2026$1.15$1.17
+1.74%		$1.24$1.1643,686 shs$2.67 million
08/10/2026$1.20$1.15
-4.17%		$1.24$1.0782,713 shs$2.62 million
08/07/2026$1.37$1.20
-12.41%		$1.26$1.18184,165 shs$2.74 million
08/06/2026$1.18$1.37
+16.10%		$1.60$1.101.22 million shs$3.12 million
08/05/2026$1.02$1.18
+15.69%		$1.32$1.05577,177 shs$2.69 million
08/04/2026$1.05$1.02
-2.86%		$1.10$0.9845,584 shs$2.33 million
08/03/2026$1.01$1.05
+3.96%		$1.07$1.0075,464 shs$2.39 million
Related Companies

This page (NASDAQ:PPCB) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Man Who Called SpaceX Rise Says Elon’s NEW Project is Even Bigger
James Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover...
Paradigm Press | Sponsoredtc pixel
Half the market is standing on a trapdoor
Nearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been...
Behind the Markets | Sponsoredtc pixel
Wall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!)
The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Mo...
Weiss Ratings | Sponsoredtc pixel